Literature DB >> 27346349

IκB Kinase ε Is an NFATc1 Kinase that Inhibits T Cell Immune Response.

Junjie Zhang1, Hao Feng2, Jun Zhao1, Emily R Feldman3, Si-Yi Chen1, Weiming Yuan1, Canhua Huang4, Omid Akbari1, Scott A Tibbetts3, Pinghui Feng5.   

Abstract

Activation of nuclear factor of activated T cells (NFAT) is crucial for immune responses. IKKε is an IκB kinase (IKK)-related kinase, and the function of IKKε remains obscure in T cells, despite its abundant expression. We report that IKKε inhibits NFAT activation and T cell responses by promoting NFATc1 phosphorylation. During T cell activation, IKKε was transiently activated to phosphorylate NFATc1. Loss of IKKε elevated T cell antitumor and antiviral immunity and, therefore, reduced tumor development and persistent viral infection. IKKε was activated in CD8(+) T cells of mice bearing melanoma or persistently infected with a model herpesvirus. These results collectively show that IKKε promotes NFATc1 phosphorylation and inhibits T cell responses, identifying IKKε as a crucial negative regulator of T cell activation and a potential target for immunotherapy.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27346349      PMCID: PMC5293007          DOI: 10.1016/j.celrep.2016.05.083

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  45 in total

1.  IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex.

Authors:  R T Peters; S M Liao; T Maniatis
Journal:  Mol Cell       Date:  2000-03       Impact factor: 17.970

2.  Requirement for balanced Ca/NFAT signaling in hematopoietic and embryonic development.

Authors:  Martin R Müller; Yoshiteru Sasaki; Irena Stevanovic; Edward D Lamperti; Srimoyee Ghosh; Sonia Sharma; Curtis Gelinas; Derrick J Rossi; Matthew E Pipkin; Klaus Rajewsky; Patrick G Hogan; Anjana Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-07       Impact factor: 11.205

3.  Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells.

Authors:  Jinjong Myoung; Don Ganem
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

4.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

5.  T cell metabolism. The protein LEM promotes CD8⁺ T cell immunity through effects on mitochondrial respiration.

Authors:  Isobel Okoye; Lihui Wang; Katharina Pallmer; Kirsten Richter; Takahuru Ichimura; Robert Haas; Josh Crouse; Onjee Choi; Dean Heathcote; Elena Lovo; Claudio Mauro; Reza Abdi; Annette Oxenius; Sophie Rutschmann; Philip G Ashton-Rickardt
Journal:  Science       Date:  2015-04-16       Impact factor: 47.728

6.  The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation.

Authors:  Katarzyna Bulek; Caini Liu; Shadi Swaidani; Liwen Wang; Richard C Page; Muhammet F Gulen; Tomasz Herjan; Amina Abbadi; Wen Qian; Dongxu Sun; Mark Lauer; Vincent Hascall; Saurav Misra; Mark R Chance; Mark Aronica; Thomas Hamilton; Xiaoxia Li
Journal:  Nat Immunol       Date:  2011-08-07       Impact factor: 25.606

7.  Murine gamma-herpesvirus 68 hijacks MAVS and IKKbeta to initiate lytic replication.

Authors:  Xiaonan Dong; Hao Feng; Qinmiao Sun; Haiyan Li; Ting-Ting Wu; Ren Sun; Scott A Tibbetts; Zhijian J Chen; Pinghui Feng
Journal:  PLoS Pathog       Date:  2010-07-29       Impact factor: 6.823

8.  NF-κB factors control the induction of NFATc1 in B lymphocytes.

Authors:  Khalid Muhammad; Hani Alrefai; Ralf Marienfeld; Duong Anh Thuy Pham; Krisna Murti; Amiya K Patra; Andris Avots; Valesca Bukur; Ugur Sahin; Eisaku Kondo; Stefan Klein-Hessling; Edgar Serfling
Journal:  Eur J Immunol       Date:  2014-09-26       Impact factor: 5.532

9.  Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation.

Authors:  Jessica E Hutti; Rhine R Shen; Derek W Abbott; Alicia Y Zhou; Kam M Sprott; John M Asara; William C Hahn; Lewis C Cantley
Journal:  Mol Cell       Date:  2009-05-14       Impact factor: 17.970

10.  Unanchored K48-linked polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKε kinase-mediated antiviral response.

Authors:  Ricardo Rajsbaum; Gijs A Versteeg; Sonja Schmid; Ana M Maestre; Alan Belicha-Villanueva; Carles Martínez-Romero; Jenish R Patel; Juliet Morrison; Giuseppe Pisanelli; Lisa Miorin; Maudry Laurent-Rolle; Hong M Moulton; David A Stein; Ana Fernandez-Sesma; Benjamin R tenOever; Adolfo García-Sastre
Journal:  Immunity       Date:  2014-05-29       Impact factor: 31.745

View more
  20 in total

Review 1.  Roles of IκB kinase ε in the innate immune defense and beyond.

Authors:  Junjie Zhang; Mao Tian; Zanxian Xia; Pinghui Feng
Journal:  Virol Sin       Date:  2016-12-28       Impact factor: 4.327

2.  Species-Specific Deamidation of cGAS by Herpes Simplex Virus UL37 Protein Facilitates Viral Replication.

Authors:  Junjie Zhang; Jun Zhao; Simin Xu; Junhua Li; Shanping He; Yi Zeng; Linshen Xie; Na Xie; Ting Liu; Katie Lee; Gil Ju Seo; Lin Chen; Alex C Stabell; Zanxian Xia; Sara L Sawyer; Jae Jung; Canhua Huang; Pinghui Feng
Journal:  Cell Host Microbe       Date:  2018-08-08       Impact factor: 21.023

3.  Fascin1 suppresses RIG-I-like receptor signaling and interferon-β production by associating with IκB kinase ϵ (IKKϵ) in colon cancer.

Authors:  Tomio Matsumura; Shigeaki Hida; Masato Kitazawa; Chifumi Fujii; Akira Kobayashi; Michiko Takeoka; Shun-Ichiro Taniguchi; Shin-Ichi Miyagawa
Journal:  J Biol Chem       Date:  2018-03-01       Impact factor: 5.157

4.  Hyper activation of β-catenin signalling induced by IKKε inhibition thwarts colorectal cancer cell proliferation.

Authors:  Jie Chen; Jun Zhao; Xuan Chen; Chengming Ding; Katie Lee; Zeming Jia; Yaoting Zhang; Yuzheng Zhou; Chaoying Wei; Jiantai He; Zanxian Xia; Jian Peng
Journal:  Cell Prolif       Date:  2017-05-19       Impact factor: 6.831

5.  The CCCH-Type Zinc Finger Antiviral Protein Relieves Immunosuppression of T Cells Induced by Avian Leukosis Virus Subgroup J via the NLP-PKC-δ-NFAT Pathway.

Authors:  Mingjun Zhu; Jing Zhou; Defang Zhou; Kunmei Yang; Bin Li; Ziqiang Cheng
Journal:  J Virol       Date:  2021-10-27       Impact factor: 6.549

6.  Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-TNFα withdrawal.

Authors:  Jing Yao Leong; Phyllis Chen; Joo Guan Yeo; Fauziah Ally; Camillus Chua; Sharifah Nur Hazirah; Su Li Poh; Lu Pan; Liyun Lai; Elene Seck Choon Lee; Loshinidevi D/O Thana Bathi; Thaschawee Arkachaisri; Daniel Lovell; Salvatore Albani
Journal:  Ann Rheum Dis       Date:  2019-09-20       Impact factor: 19.103

7.  IκB-kinase-ε in the tumor microenvironment is essential for the progression of gastric cancer.

Authors:  Biao Geng; Chen Zhang; Chao Wang; Ying Che; Xianmin Mu; Jinshun Pan; Che Xu; Shi Hu; Jing Yang; Ting Zhao; Yue Xu; Yuanfang Lv; Hao Wen; Zheng Liu; Qiang You
Journal:  Oncotarget       Date:  2017-09-08

8.  Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients.

Authors:  Niki Karachaliou; Maria Gonzalez-Cao; Guillermo Crespo; Ana Drozdowskyj; Erika Aldeguer; Ana Gimenez-Capitan; Cristina Teixido; Miguel Angel Molina-Vila; Santiago Viteri; Maria De Los Llanos Gil; Salvador Martin Algarra; Elisabeth Perez-Ruiz; Ivan Marquez-Rodas; Delvys Rodriguez-Abreu; Remedios Blanco; Teresa Puertolas; Maria Angeles Royo; Rafael Rosell
Journal:  Ther Adv Med Oncol       Date:  2018-01-18       Impact factor: 8.168

Review 9.  TANK-Binding Kinase 1-Dependent Responses in Health and Autoimmunity.

Authors:  Cynthia Louis; Chris Burns; Ian Wicks
Journal:  Front Immunol       Date:  2018-03-06       Impact factor: 7.561

10.  Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

Authors:  Russell W Jenkins; Amir R Aref; Patrick H Lizotte; Elena Ivanova; Susanna Stinson; Chensheng W Zhou; Michaela Bowden; Jiehui Deng; Hongye Liu; Diana Miao; Meng Xiao He; William Walker; Gao Zhang; Tian Tian; Chaoran Cheng; Zhi Wei; Sangeetha Palakurthi; Mark Bittinger; Hans Vitzthum; Jong Wook Kim; Ashley Merlino; Max Quinn; Chandrasekar Venkataramani; Joshua A Kaplan; Andrew Portell; Prafulla C Gokhale; Bart Phillips; Alicia Smart; Asaf Rotem; Robert E Jones; Lauren Keogh; Maria Anguiano; Lance Stapleton; Zhiheng Jia; Michal Barzily-Rokni; Israel Cañadas; Tran C Thai; Marc R Hammond; Raven Vlahos; Eric S Wang; Hua Zhang; Shuai Li; Glenn J Hanna; Wei Huang; Mai P Hoang; Adriano Piris; Jean-Pierre Eliane; Anat O Stemmer-Rachamimov; Lisa Cameron; Mei-Ju Su; Parin Shah; Benjamin Izar; Manisha Thakuria; Nicole R LeBoeuf; Guilherme Rabinowits; Viswanath Gunda; Sareh Parangi; James M Cleary; Brian C Miller; Shunsuke Kitajima; Rohit Thummalapalli; Benchun Miao; Thanh U Barbie; Vivek Sivathanu; Joshua Wong; William G Richards; Raphael Bueno; Charles H Yoon; Juan Miret; Meenhard Herlyn; Levi A Garraway; Eliezer M Van Allen; Gordon J Freeman; Paul T Kirschmeier; Jochen H Lorch; Patrick A Ott; F Stephen Hodi; Keith T Flaherty; Roger D Kamm; Genevieve M Boland; Kwok-Kin Wong; David Dornan; Cloud Peter Paweletz; David A Barbie
Journal:  Cancer Discov       Date:  2017-11-03       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.